1. A comparison of the efficacy and tolerability of the PCSK9 inhibitors, Alirocumab and evolocumab, in routine lipid clinic practice. (August 2017) Authors: Jones, Alan; Peers, Kate; Ramachandran, Sud; Syed, Ateeq Journal: Atherosclerosis Issue: Volume 263(2017) Page Start: e247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Incidental finding of lipaemia retinalis on diabetic retinal screening. (20th October 2021) Authors: Kempegowda, Punith; Chen, Wentin; Melson, Eka; Leong, Annabelle; Amrelia, Prashant; Syed, Ateeq Journal: Endocrinology, diabetes & metabolism case reports Issue: (2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Retinopathy and microalbuminuria are common microvascular complications in cystic fibrosis-related diabetes. (October 2020) Authors: Kempegowda, Punith; Sunsoa, Harbinder; Chandan, Joht S.; Quinn, Lauren M.; Amrelia, Prashant M.; Atta, Syed Noman; Amir, Sidrah; Teh, Yee Suh; Chaudhry, Sabba; de Bray, Anne; Rashid, Rifat; Whitehouse, Joanna L.; Nash, Edward F.; Syed, Ateeq Journal: Therapeutic advances in endocrinology and metabolism Issue: Volume 11(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SQUID DKA – baseline audit of diabetic ketoacidosis management at a large NHS foundation trust in the West Midlands. (2019) Authors: Kempegowda, Punith; Noorin, Amna; Ishaq, Ayesha; Syed, Ateeq; Karamat, Muhammad Journal: Future healthcare journal Issue: Volume 6(2019)Supplement 1 Page Start: s12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗